Compare Mesoblast Limited (MESO) vs State Street Real Estate Select Sector SPDR ETF (XLRE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs State Street Real Estate Select Sector SPDR ETF — how do they compare? Mesoblast Limited trades at $16.31 (market cap $2.11B), while State Street Real Estate Select Sector SPDR ETF trades at $44.99. The key difference: State Street Real Estate Select Sector SPDR ETF is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.
| MESO | XLRE | |
|---|---|---|
Market Cap | $2.11B | — |
Sector | Technology | Sector/Thematic |
52-Week High | $20.96 | $45.46 |
52-Week Low | $12.88 | $40.01 |
Enterprise Value | $2.11B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MESO trades at $16.63, down 3.98% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $36 million for Ryoncil, showing strong commercial progress, but maintains a net income margin of -144.33% with significant losses. Recent news highlights pivotal Phase 3 trial milestones for chronic low back pain treatment and a $50 million non-dilutive financing draw.
Outlook is mixed: bullish analyst sentiment and clinical advancements offer upside potential, but high cash burn and persistent losses pose substantial risks. Investors should weigh the company's growth trajectory against its financial sustainability and regulatory milestones.
XLRE, the Real Estate Select Sector SPDR ETF, trades at $45.23 with a slight 0.42% decline. Technical indicators show a bullish trend with strong moving average support, though RSI suggests potential overbought conditions. The ETF has gained 11% year-to-date, benefiting from REIT sector recovery despite interest rate volatility. Recent news highlights XLRE's low 0.08% expense ratio advantage and steady dividend yield around 3.4%.
Outlook remains cautiously optimistic as REIT fundamentals improve with stable NOI growth and potential M&A activity. Key risks include interest rate sensitivity and inflation pressures. Wall Street sentiment is positive with the sector showing resilience amid broader market volatility, though investors should monitor Fed policy shifts that could impact real estate valuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About State Street Real Estate Select Sector SPDR ETF
XLRE tracks the Real Estate Select Sector Index, providing exposure to S&P 500 real estate companies. It focuses on equity REITs across residential, industrial, and healthcare sub-sectors, with top holdings like Welltower, Prologis, and American Tower.
Read more on XLRE →
